Merck | search
Click here to view Merck news from 60+ newspapers.
Bookmark or Share- Merck Announces Third-Quarter 2024 Financial ResultsMerck now expects its full-year non-GAAP effective income tax rate to be between 16.0% and 17.0%, which includes an unfavorable impact related to the one-time charge associated with the acquisition of CN201 (MK-1045) from Curon.
- Merck Enters into Exclusive Global License for LM-299, An ...“This agreement adds to Merck’s growing oncology pipeline and we look forward to advancing LM-299 with speed and rigor for patients in need.” Under the agreement, LaNova has granted Merck an exclusive global license to develop, manufacture and commercialize LM-299. LaNova will receive an upfront payment of $588 million.
- Discover Job Opportunities at Merck | Merck CareersExplore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and Marketing.
- Products list - Merck.comFor information about Merck’s products and services including the reporting of an Adverse Event or Product Quality Complaint with a specific Merck product, please call the Merck National Service Center.
- Our Q3 2024 financial results - Merck.comMerck’s Q3 2024 financial results represent strong progress across the business and our diverse pipeline. Our company announced worldwide sales of $16.7 billion, an increase of 4% from Q3 2023.
More
